Onconetix, Inc. Stock Issued During Period, Value, Employee Benefit Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Onconetix, Inc. stock issued during period, value, employee benefit plan for the quarter ending 2025-06-30 was $345.32K.
- Onconetix, Inc. stock issued during period, value, employee benefit plan for the quarter ending 2025-03-31 was $30.78K.
- Onconetix, Inc. stock issued during period, value, employee benefit plan for fiscal 2024 was $238.01K, a 3891.45% increase from fiscal 2023.
- Onconetix, Inc. stock issued during period, value, employee benefit plan for fiscal 2023 was $5.96K.
| Period end | Stock Issued During Period, Value, Employee Benefit Plan 3 month | Stock Issued During Period, Value, Employee Benefit Plan 12 month |
|---|---|---|
| 2025-06-30 | $345.32K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $30.78K 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $238.01K 10-K · filed 2025-06-02 | |
| 2023-12-31 | $5.96K 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |